Anti-Golgi antibodies: Letme look around;Autoanticorpi anti-Golgi: Anche l'occhio vuole la sua parte

Recenti Progressi in Medicina

Volumn 102, Issue 1, 2011, Pages 11-13

  Valaperta, Serenella ^a   Alpini, Claudia ^b   Bottone, Maria Grazia ^c   Monari, Marta ^a   Assandri, Roberto ^a   Montanelli, Alessandro ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Autoantibodies; Golgi complex; Golgins; Indirect immunofluorescence

Indexed keywords

AUTOANTIBODY; GOLGI ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BIOTECHNOLOGY; GOLGI COMPLEX; IMMUNOFLUORESCENCE;

AUTOANTIBODIES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GOLGI APPARATUS; HUMANS;

EID: 79951520337     PISSN: 00341193     EISSN: 20381840     Source Type: Journal    
DOI: 10.1701/545.6467     Document Type: Article

References (8)

1. Fritzler MJ. The clinical paradox of esoteric and novel autoantibodies. In: Conrad K, Chan EKL, Fritzler MJ, Humbel RL, von Landenberg P, Shoenfeld Y (eds). From pathogenesis to therapy of autoimmune diseases. Proceedings 9th Dresden Symposium on Autoantibodies on September 2-5, 2009. Pabst Science Publishers 2009; p. 71-87.
2. Fritzler MJ, Fritzler ML. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr Med Chem 2006; 13: 2503-12. (Pubitemid 44364152)
3. Mazzarello P, Garbarino C, Calligaro A. How Camillo Golgi became "the Golgi". FEBS Lett 2009 Oct 13.
4. Stinton LM, Eystathioy T, Selak S, Chan EKL, Fritzler J. Autoantibodies to protein transport and messenger RNA processing pathway: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol 2004; 110: 30-44. (Pubitemid 38177418)
5. Barr FA, Short B. Golgins in the structure and dynamics of Golgi apparatus. Curr Opin Cell Biol 2003; 15: 405-13. (Pubitemid 36928042)
6. Kooy J, Toh BH, Gleeson PA. Heterogeneity of human anti-Golgi auto-antibodies: reactivity with components from 35 to 260 kDa. Immunol Cell Biol 1994; 72: 123-27. (Pubitemid 24135451)
7. Paranà R, Schinoni MI, de Freitas LA, Codes L, Cruz M, Andrade Z, et al. Anti-Golgi complex antibodies during pegylated-interferon therapy for hepatitis C. Liver Int 2006; 26: 1148-54. (Pubitemid 44541756)
8. Bizzaro N, Pasini P, Ghirardello A, Finco B. High anti-Golgi autoantibody levels: an early sign of autoimmune disease? Clin Rheumatol 1999; 18: 346-48.